A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 9, 2002, Pages 1189-1194

  Takenaga, Mitsuko ^a   Yamaguchi, Yoko ^a   Kitagawa, Aki ^a   Ogawa, Yasuaki ^a   Mizushima, Yutaka ^a   Igarashi, Rie ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; HUMULIN U; INSULIN; LONG ACTING DRUG; POLYGLACTIN; RECOMBINANT HUMAN INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; FEMALE; HYPERGLYCEMIA; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MICROCAPSULE; MONKEY; NONHUMAN; RAT; STEADY STATE; SUSTAINED RELEASE FORMULATION; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HYPERGLYCEMIA; INSULIN; MACACA FASCICULARIS; MALE; RATS; RATS, WISTAR;

EID: 0036732078     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702320402026     Document Type: Article

References (26)

1. Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats
2. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method
3. Isolation and characterization of a cloned rat insulin gene
4. One month of sustained release of insulin from a polymer implant
5. New concept for long-acting insulin; Spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-Fluorenyl-methoxycarbonyl derivative of insulin
6. Slow release of insulin from a biodegradable matrix implanted in diabetic rats
7. New developments in the treatment of type 1 diabetes mellitus
8. Polymeric lammelar substrate particles for intranasal vaccination
9. Practical concept for insulin therapy
10. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes
11. Protein measurement with the folin phenol reagent
12. Injectable microcapsules prepared with biodegradable poly(alpha-hydroxy)acids for prolonged release of drugs
13. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers
14. Pharmacokinetics of 125I-labeled insulin glargine (HOE901) in healthy men
15. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles
16. Efficacy of safety of HOE 901 versus NPH insulin in patients with type 1 diabetes
17. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants
18. Dose-response characteristics for effects of insulin on production and utilization of glucose in man
19. Application of a spray drying technique in the production of TRH-containing injectable sustained release microparticles of biodegradable polymers
20. Sustained release of a water-soluble GPIIb/IIIa antagonist from copoly(DL-lactic/glycolic)acid microspheres
21. Utilization of an amorphous form of a water soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres
22. A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release
23. Synthetic delivery system for tuberculosis vaccines: Immunological evaluation of the M. Tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles
24. Insulin-loaded biodegradable PLGA microcapsules-initial burst release controlled by the hydrophilic additives
25. Antitumor effect of arterial administration of medium-chain triglyceride solution of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX-2 carcinoma
26. Isolation of amino acid sequences of squirrel monkey (Saimiri sciurea) insulin and glucagon